HEPATOCELLULAR CARCINOMA BY BCLC STAGE
Clinical trials for HEPATOCELLULAR CARCINOMA BY BCLC STAGE explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CARCINOMA BY BCLC STAGE trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CARCINOMA BY BCLC STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for liver cancer patients with damaged livers?
Disease control CompletedThis study tested a drug called tislelizumab in 50 adults with advanced liver cancer and moderate liver damage (Child-Pugh B). The goal was to see if the drug could shrink tumors and how safe it was. Participants received tislelizumab alone, and the study measured how many had th…
Matched conditions: HEPATOCELLULAR CARCINOMA BY BCLC STAGE
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
Brazilian liver cancer study reveals Real-World treatment patterns
Knowledge-focused CompletedThis study reviewed medical records of 300 liver cancer patients in Brazil to understand their health history, treatments, and outcomes. It did not test any new drug or therapy. The goal was to gather real-world information to help doctors better manage the disease.
Matched conditions: HEPATOCELLULAR CARCINOMA BY BCLC STAGE
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC